The role of 5′ untranslated region in translational suppression of OKL38 mRNA in hepatocellular carcinoma

Oncogene

Volumn 26, Issue 8, 2007, Pages 1155-1165

  Ong, C K ^a   Leong, C ^a   Tan, P H ^b   Van, T ^c   Huynh, H ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c Binh Dan Hospital   (Viet Nam)

Author keywords

5 untranslated region; Cell death; Hepatocellular carcinoma; OKL38; Translational suppression

Indexed keywords

MESSENGER RNA; PROTEIN DERIVATIVE; PROTEIN OKL38; UNCLASSIFIED DRUG; OKL38 PROTEIN, HUMAN; PROTEIN;

5' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CELL DEATH; DISEASE COURSE; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RNA TRANSLATION; WESTERN BLOTTING; CANCER STAGING; CHEMISTRY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN SYNTHESIS;

5' UNTRANSLATED REGIONS; CARCINOMA, HEPATOCELLULAR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NEOPLASM STAGING; PROTEIN BIOSYNTHESIS; PROTEINS; RNA, MESSENGER; SEQUENCE DELETION;

EID: 33847193819     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209896     Document Type: Article

References (29)

1. Akriviadis EA, Llovet JM, Efremidis SC, Shouval D, Canelo R, Ringe B et al. (1998). Hepatocellular carcinoma. Br J Surg 85: 1319-1331.
2. Altman DG, Machin D, Bryant TN, Gardner MJ. (2000). Statistics With Confidence. British Medical Journal Books: London.
3. Chan ES, Chow PK, Tai B, Machin D, Soo K. (2000). Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma. Cochrane Database Systemic Review (CD001199pp).
4. Claudio PP, Zamparelli A, Garcia FU, Claudio L, Ammirati G, Farina A et al. (2002). Expression of cell-cycle-regulated proteins PRb2/P130, P107, P27(Kip1), P53, Mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma. Clin Cancer Res 8: 1808-1815.
5. Clemens MJ. (2004). Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 23: 3180-3188.
6. Colombo M. (1992). Hepatocellular carcinoma. J Hepatol 15: 225-236.
7. Dua K, Williams TM, Beretta L. (2001). Translational control of the proteome: relevance to cancer. Proteomics 1: 1191-1199.
8. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD et al. (2005). The Proteomics Protocols Handbook Walker JM (ed). Humana Press: Totowa, NJ. pp 571-608.
9. Harigai M, Miyashita T, Hanada M, Reed JC. (1996). A cis-acting element in the BCL-2 gene controls expression through translational mechanisms. Oncogene 12: 1369-1374.
10. Huguet CSFaGA. (2000). Surgery of the Liver and Billary Tract Blumgart L (ed). Churchill Livingstone: London. pp 1365-1369.
11. Huynh H, Chow PK, Ooi LL, Soo KC. (2002). A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. Cell Growth Differ 13: 115-122.
12. Huynh H, Ng CY, Ong CK, Lim KB, Chan TW. (2001). Cloning and characterization of a novel pregnancy-induced growth inhibitor in mammary gland. Endocrinology 142: 3607-3615.
13. Kozak M. (1987). An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15: 8125-8148.
14. Kozak M. (1991). An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 115: 887-903.
15. Kullmann M, Gopfert U, Siewe B, Hengst L. (2002). ELAV/Hu proteins inhibit P27 translation via an IRES element in the P27 5′UTR. Genes Dev 16: 3087-3099.
16. Lai Ea WJ. (1994). Surgery of the Liver and the Biliary Tract Blumgart L (ed). Churchill Livingstone: London. pp 1349-1363.
17. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. (1995). Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 221: 291-298.
18. Meijer HA, Thomas AA. (2002). Control of eukaryotic protein synthesis by upstream open reading frames in the 5′-untranslated region of an MRNA. Biochem J 367: 1-11.
19. Morris DR, Geballe AP. (2000). Upstream open reading frames as regulators of mRNA translation. Mol Cell Biol 20: 8635-8642.
20. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H et al. (1985). Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56: 918-928.
21. Ong CK, Ng CY, Leong C, Ng CP, Foo KT, Tan PH et al. (2004a). Genomic structure of human OKL38gene and its differential expression in kidney carcinogenesis. J Biol Chem 279: 743-754.
22. Ong CK, Ng CY, Leong C, Ng CP, Ong CS, Nguyen TT et al. (2004b). Structural characterization of three novel rat OKL38transcripts, their tissue distributions, and their regulation by human chorionic gonadotropin. Endocrinology 145: 4763-4774.
23. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
24. Pickering BM, Willis AE. (2005). The implications of structured 5′ untranslated regions on translation and disease. Semin Cell Dev Biol 16: 39-47.
25. Riou P, Saffroy R, Comoy J, Gross-Goupil M, Thiery JP, Emile JF et al. (2002). Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma. Clin Cancer Res 8: 3178-3186.
26. Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH et al. (1992). In: Spiessl B (ed). Illustrated Guide to the TNM/PTNM Classification of Malignant Tumour, 3rd edn, 2nd rev. Springer Verlag: Berlin, Heidelberg, New York. pp 104-111.
27. Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H et al. (1996). Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 131: 71-76.
28. Wang T, Xia D, Li N, Wang C, Chen T, Wan T et al. (2005). Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis. J Biol Chem 280: 4374-4382.
29. Willis AE. (1999). Translational control of growth factor and proto-oncogene expression. Int J Biochem Cell Biol 31: 73-86.